Unblinded Results from a dose-escalating placebo-controlled study with allogeneic bone marrow-derived mesenchymal stem cells for the treatment of refractory perianal fistulas in patients with Crohn's disease

Author(s):
Molendijk, I.; Bonsing, B.A.; Roelofs, H.; Peeters, K.C.; Wasser, M.N.; Veenendaal, R.A.; Zwaginga, J.J.; Verspaget, H.W.; Fibbe, W.E. (0000-0001-8539-9011); Meulen-de Jong, A.E. van der; Hommes, D.W.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-02-28
Language
English
Is part of
Journal of Crohn's and Colitis (2015), Vol. 9, p. S254-S255
hdl
1887/106583